You are using an outdated browser and your browsing experience will not be optimal. Please update to the latest version of Microsoft Edge, Google Chrome or Mozilla Firefox. Install Microsoft Edge

May 21, 2020

Atthachai Homhuan and Kittiya Nopparatrungroj Speak on New Normal in Pharma and Medical Devices

On May 21, Dr. Atthachai Homhuan, manager of regulatory affairs in Tilleke & Gibbins’ Bangkok office, and Kittiya Nopparatrungroj, consultant and licensed pharmacist, will join together to present a webinar cohosted by Tilleke & Gibbins and the Thai Listed Companies Association (TLCA).

Their session, entitled “New Normal in Pharma and Medical Devices: The Impact of COVID-19,” will dive into the responses to the COVID-19 outbreak by the Thai Food and Drug Administration and the Department of Internal Trade, and how government policy may affect the production and distribution of personal protective equipment, medical devices, and pharmaceutical products. Immediately following the webinar, Atthachai and Kittiya will respond to attendee questions through a brief Q&A session.

The webinar, which will be conducted in Thai language, will go live on Thursday, May 21, at 2:00 p.m. If you’re interested in attending, please register for the webinar by sending an email to [email protected].

RELATED INSIGHTS​ 

February 1, 2017
Tilleke & Gibbins has been nominated for the Thailand Law Firm of the Year Award 2017 by Chambers Asia-Pacific. The firm has been nominated for the award six times since 2010, and was honored to win the Thailand Law Firm of the Year Award 2014. This year’s winner will be announced at Chambers Asia-Pacific’s annual ceremony and dinner, which will be held at The Fullerton Hotel in Singapore on March 24, 2017.
October 13, 2016
Tilleke & Gibbins, together with EuroCham Vietnam, will hold a seminar focusing on legal issues in the pharmaceutical sector. The seminar will feature a panel of pharmaceutical and intellectual property experts from Japan, Thailand, and Vietnam, and it will provide attendees with an in-depth look at emerging issues in Vietnam’s rapidly developing pharmaceutical sector, including: